In this new article, Luigi Pavia, Ecosystem Engagement & Partnerships at Frontiers Health, reflects on a quiet but meaningful shift in health innovation partnerships.
XO Life, the Munich-based patient-pharma platform, has closed a €4 million funding round led by Fil Rouge Capital, with participation from existing investors Sandwater, Grazia Equity, Vi Partners, and Bayern Kapital.